Glenmark Pharmaceuticals (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Glenmark Pharmaceuticals" in English language version.

refsWebsite

Global rank English rank

3indiatimes.com

17^th place

15^th place

2livemint.com

390^th place

227^th place

2business-standard.com

350^th place

206^th place

2nih.gov

4^th place

1glenmarkpharma.com

low place

1edudwar.com

low place

1books.google.com

3^rd place

1forbes.com

54^th place

48^th place

1fiercepharma.com

low place

8,921^st place

1businesstoday.in

1,332^nd place

708^th place

1bloomberg.com

99^th place

77^th place

1kabarluwuraya.com

low place

1medicaldialogues.in

low place

1newindianexpress.com

188^th place

118^th place

1biospectrumindia.com

low place

1reuters.com

49^th place

47^th place

1cnbctv18.com

4,062^nd place

2,178^th place

1ndtv.com

138^th place

95^th place

1bloombergquint.com

7,123^rd place

3,897^th place

1doi.org

2^nd place

1thehindubusinessline.com

724^th place

431^st place

1deccanherald.com

516^th place

291^st place

biospectrumindia.com

"Glenmark gets FDA nod of company's first NDA for Ryaltris". Biospectrum. 8 August 2018. Retrieved 20 July 2019.

bloomberg.com

Altstedter, Ari (15 July 2016). "Glenmark Expects Cash Surge From License Deals in Next 18 Months". Bloomberg.com.

bloombergquint.com

"Glenmark Launches Covid-19 Drug At Rs 103 A Tablet". BloombergQuint.

books.google.com

Hiscock, Geoff (2008). India's Global Wealth Club: The Stunning Rise of Its Billionaires and Their Secrets of Success. John Wiley & Sons. pp. 65–66. ISBN 9780470822388.

business-standard.com

Singh, Anjali (3 January 2024). "Glenmark cuts diabetes drug cost by 70% with first Indian biosimilar launch". Business Standard. Retrieved 28 June 2024.
"Glenmark Pharmaceuticals launches antidiabetic drug 'Lirafit' in India". Business Standard. 3 January 2024. Retrieved 28 June 2024.

businesstoday.in

"Glenmark, Torrent Pharma ink pact to co-market diabetes drug in India". Business Today. 11 July 2019. Retrieved 20 July 2019.

cnbctv18.com

"Glenmark launches Favipiravir for treatment of mild to moderate COVID-19 patients". cnbctv18.com.

deccanherald.com

PTI. "Pfizer, Glenmark join hands to launch skin disease drug in India". Deccan Herald. Retrieved 28 June 2024.

doi.org

Şimşek Yavuz, S; Ünal, S (21 April 2020). "Antiviral treatment of COVID-19". Turkish Journal of Medical Sciences. 50 (SI-1): 611–619. doi:10.3906/sag-2004-145. PMC 7195979. PMID 32293834.

edudwar.com

"Know 10 largest Pharmaceutical Companies in India". Edu Dwar. Retrieved 31 May 2023.

fiercepharma.com

Levin, Jennifer. "5. Glenmark Pharmaceuticals". FiercePharma.

forbes.com

"India's Richest: #69 Gracias Saldanha". Forbes. 2011.

glenmarkpharma.com

"Glenmark AR 2022-23" (PDF).

indiatimes.com

economictimes.indiatimes.com

"Emerging Company of the Year : Glenmark Pharmaceuticals". The Economic Times. 27 October 2007. Retrieved 3 August 2023.
"Emerging Company of the Year : Glenmark Pharmaceuticals". The Economic Times. 27 October 2007.

health.economictimes.indiatimes.com

www.ETHealthworld.com. "Glenmark partners with Pfizer to launch Abrocitinib in India - ET HealthWorld | Pharma". ETHealthworld.com | Pharma. Retrieved 28 June 2024.

kabarluwuraya.com

Seo, Don (30 July 2024). "India Pharmaceutical Sector – Small Growth in Sales during FY 2016-17". KabarLuwuRaya.

livemint.com

Altstedter, Ari (18 May 2017). "Glenmark's Glenn Saldanha seeks a new holy grail as generic drugs run dry". Live Mint.
Trivedi, Isha (22 December 2016). "We plan to out-license our entire novel drugs pipeline: Glenmark CMD". Live Mint.

medicaldialogues.in

business.medicaldialogues.in

"Glenmark appoints Yasir Rawjee as CEO of Glenmark Life Sciences". Medical Dialogues. 8 May 2019.

ndtv.com

"Glenmark Launches COVID-19 Drug Favipiravir At Rs 103 Per Tablet". NDTV.com.

newindianexpress.com

Bajeli-Datt, Kavita (25 September 2024). "Antacid Pan D, Paracetamol, Glimepiride among over 50 drugs that fail quality test". The New Indian Express. Retrieved 5 October 2024.

nih.gov

ncbi.nlm.nih.gov

Şimşek Yavuz, S; Ünal, S (21 April 2020). "Antiviral treatment of COVID-19". Turkish Journal of Medical Sciences. 50 (SI-1): 611–619. doi:10.3906/sag-2004-145. PMC 7195979. PMID 32293834.

pubmed.ncbi.nlm.nih.gov

Şimşek Yavuz, S; Ünal, S (21 April 2020). "Antiviral treatment of COVID-19". Turkish Journal of Medical Sciences. 50 (SI-1): 611–619. doi:10.3906/sag-2004-145. PMC 7195979. PMID 32293834.

reuters.com

"Glenmark Pharmaceuticals Submitts NDA To U.S. FDA For Ryaltris". Reuters. 21 May 2018. Retrieved 20 July 2019.

thehindubusinessline.com

"Glenmark to launch higher strength Favipiravir to reduce pill-burden to patients". @businessline. The Hindu BusinessLine.